Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data	3 Months Ended		9 Months Ended		73 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011
Revenues		$ (2)
Cost of sales		(1)
Gross margin		(1)
Operating costs and expenses
Research and development	975	1,026	2,480	2,106	12,051
Selling, general and administrative	506	712	1,627	1,758	8,316
Total operating costs and expenses	1,481	1,738	4,107	3,864	20,367
Operating loss	(1,481)	(1,739)	(4,107)	(3,864)	(20,367)
Other income and expense
Other income					1,147
Interest (expense) income, net	(7)	1	(7)	1	8
Amortization of debt issuance expense	(5)	(26)	(36)	(179)	(1,969)
Total other income and expense	(12)	(25)	(43)	(178)	(814)
Loss before income tax	(1,493)	(1,764)	(4,150)	(4,042)	(21,181)
Provision for income tax	0	0	0	0	0
Net loss	(1,493)	(1,764)	(4,150)	(4,042)	(21,181)
Loss attributable to common stockholders and loss per common share:
Net loss	(1,493)	(1,764)	(4,150)	(4,042)	(21,181)
Net loss attributable to common stockholders	(1,493)	(6,145)	(4,150)	(9,121)	(26,548)
Weighted average shares outstanding, basic and diluted	28,004	24,041	28,004	20,285
Net loss per basic and diluted share	$ (0.05)	$ (0.26)	$ (0.15)	$ (0.45)
Series A Preferred Stock
Loss attributable to common stockholders and loss per common share:
Deemed dividend				(500)	(700)
Dividends - Series A Preferred Stock		(80)		(278)	(366)
Series A Preferred Conversion
Loss attributable to common stockholders and loss per common share:
Deemed dividend		$ (4,301)		$ (4,301)	$ (4,301)